[1] |
World Health Organization. Global tuberculosis report 2018. Geneva: World Health Organization, 2018.
|
[2] |
杨文英 . 中国糖尿病的流行特点及变化趋势. 中国科学, 2018,48(8):812-819.
|
[3] |
Park SW, Shin JW, Kim JY , et al. The effect of diabetic control status on the clinical features of pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis, 2012,31(7):1305-1310.
|
[4] |
Baker MA, Harries AD, Jeon CY , et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med, 2011,9:81.
|
[5] |
Wu Z, Guo J, Huang Y , et al. Diabetes mellitus in patients with pulmonary tuberculosis in an aging population in Shanghai, China: prevalence, clinical characteristics and outcomes. J Diabetes Complications, 2016,30(2):237-241.
|
[6] |
Skevaki C, Pararas M, Kostelidou K , et al. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases. Clin Exp Immunol, 2015,180,(2):165-177.
|
[7] |
Ramstead AG, Robison A, Blackwell A , et al. Roles of Toll-like receptor 2 (TLR2), TLR4, and MyD88 during pulmonary coxiella burnetii infection. Infect Immun, 2016,84(4):940-949.
|
[8] |
Brown EJ, Albers MW, Shin TB , et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature, 1994,369(6483):756-758.
|
[9] |
Yu J, Yaba A, Kasiman C , et al. mTOR controls ovarian follicle growth by regulating granulosa cell proliferation. PLoS One, 2011,6(7):e21415.
|
[10] |
Liko D, Hall MN . mTOR in health and in sickness. J Mol Med (Berl), 2015,93(10):1061-1073.
|
[11] |
詹思延, 叶冬青, 谭红专 . 流行病学7版. 北京: 人民卫生出版社, 2012: 88-89.
|
[12] |
Li Y, Li D, Zhang J , et al. Association between Toll-like receptor 4 and occurrence of type 2 diabetes mellitus susceptible to pulmonary tuberculosis in Northeast China. Stem Cells Int, 2016,2016:8160318.
|
[13] |
World Health Organization. WHO专家咨询报告: 糖尿病的定义、诊断、分型与糖尿病并发症. 钱荣立,译 . 中国糖尿病杂志, 2000,8(1):5-6.
|
[14] |
中华人民共和国卫生部. WS 288—2008 肺结核诊断标准. 2008- 01- 16.
|
[15] |
Dobler CC, Flack JR, Marks GB . Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open, 2012,2(1):e000666.
|
[16] |
左小霞, 张晔, 王晶 . 老年糖尿病合并肺结核营养治疗的临床研究. 中国老年学杂志, 2009,29(5):588-589.
|
[17] |
Singh P, Subbian S . Harnessing the mTOR pathway for tuberculosis treatment. Front Microbiol, 2018,9:70.
|
[18] |
东方. TLR2固有免疫通路基因多态性与2型糖尿病血管病变遗传易感性的关联研究. 广州: 暨南大学, 2015.
|
[19] |
孟庆杰, 严玲霞, 刘晓宏 , 等. mTOR基因多态性与2型糖尿病及其临床特点的相关性研究. 中国糖尿病杂志, 2015,23(6):494-496.
|
[20] |
Sato M, Dehvari N, Oberg AI , et al. Improving type 2 diabetes through a distinct adrenergic signaling pathway involving mTORC2 that mediates glucose uptake in skeletal muscle. Diabetes, 2014,63(12):4115-4129.
|
[21] |
孙红梅 . TIRAP和TLR2基因多态性与结核分枝杆菌易感性相关性研究. 石家庄: 河北医科大学, 2013.
|
[22] |
Varzari A, Deyneko IV, Vladei I , et al. Genetic variation in TLR pathway and the risk of pulmonary tuberculosis in a Moldavian population. Infect Genet Evol, 2019,68:84-90.
|